Pulmonary Hypertension Trial, Recruiting NCT07453017 Sponsor: University of Sao Paulo General Hospital Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT07453017
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with, or are suspected to have, a condition called pulmonary arterial hypertension (high blood pressure in the lungs), and who have been medically recommended to have a procedure that checks blood pressure inside the heart (called a right heart catheterization).
  • People who are being assessed at the Pulmonology (lung specialist) Service at InCor-HCFMUSP.

Who may not be able to join:

  • People who are pregnant.
  • People who have certain structural problems with their heart, such as holes between heart chambers (atrial or ventricular septal defects) or problems with heart valves.
  • People who have irregular heart rhythms (cardiac arrhythmias).
  • People who have a pacemaker or any other electronic device implanted in their body.
  • People who have skin injuries or wounds on their chest area that would prevent a special sensor belt from being placed around the torso.
  • People whose heart condition is classified as the most severe level of disability (WHO/NYHA Functional Class IV) (confirm with trial site).
  • People who are unable to hold their breath voluntarily for at least 30 seconds, or who are unable to understand and follow the study instructions.
  • People who do not wish to take part, or whose attending medical team advises against participation, as indicated by not signing the consent form.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +55113061-7361

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 April 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Sensitivity (%) of Electrical Impedance Tomography (EIT)-Derived Pulsatility Amplitude for Detection of Pulmonary Hypertension Defined by Mean Pulmonary Artery Pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov